Biotechnology
The Biotechnology industry has a total of 594 stocks, with a combined market cap of $1.14 trillion and total revenue of $111.34 billion.
Market Cap
1.14T
Revenue
111.34B
Profits
-40.31B
PE Ratio
n/a
Profit Margin
-36.20%
Dividend Yield
0.04%
594 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 108.76B | 0.86% | 137,485 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 71.60B | 0.33% | 63,430 | 14.92B |
| 3 | ARGX | argenx SE | 48.73B | 2.01% | 64,556 | 4.24B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 38.69B | -2.14% | 260,355 | 4.29B |
| 5 | ONC | BeOne Medicines AG | 33.12B | 1.41% | 15,120 | 5.34B |
| 6 | RVMD | Revolution Medicines, Inc. | 30.37B | 3.53% | 430,919 | - |
| 7 | INSM | Insmed Incorporated | 29.67B | 3.15% | 284,136 | 606.42M |
| 8 | RPRX | Royalty Pharma plc | 29.53B | 0.69% | 212,188 | 2.38B |
| 9 | BNTX | BioNTech SE | 25.06B | 1.59% | 236,914 | 3.37B |
| 10 | ROIV | Roivant Sciences Ltd. | 19.89B | -0.14% | 1,632,697 | 13.31M |
| 11 | INCY | Incyte Corporation | 19.45B | 0.44% | 101,090 | 5.36B |
| 12 | MRNA | Moderna, Inc. | 18.78B | 4.30% | 1,303,694 | 2.23B |
| 13 | GMAB | Genmab A/S | 16.37B | 1.10% | 218,665 | 3.72B |
| 14 | ASND | Ascendis Pharma A/S | 13.80B | 1.09% | 49,719 | 845.52M |
| 15 | BBIO | BridgeBio Pharma, Inc. | 13.49B | 0.47% | 170,740 | 502.08M |
| 16 | SMMT | Summit Therapeutics Inc. | 13.13B | 5.00% | 2,072,422 | - |
| 17 | JAZZ | Jazz Pharmaceuticals plc | 12.71B | 1.83% | 114,072 | 4.27B |
| 18 | IONS | Ionis Pharmaceuticals, Inc. | 12.33B | -0.89% | 168,312 | 1.06B |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.91B | 1.03% | 26,304 | 958.40M |
| 20 | AXSM | Axsome Therapeutics, Inc. | 11.83B | 11.37% | 1,029,797 | 708.24M |
| 21 | EXEL | Exelixis, Inc. | 11.22B | 1.12% | 516,345 | 2.32B |
| 22 | BMRN | BioMarin Pharmaceutical Inc. | 10.54B | 0.91% | 180,620 | 3.22B |
| 23 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.53B | 0.56% | 237,643 | 1.09B |
| 24 | PRAX | Praxis Precision Medicines, Inc. | 9.25B | 2.50% | 37,569 | 7.46M |
| 25 | ABVX | ABIVAX Société Anonyme | 8.96B | -0.14% | 124,393 | 5.37M |
| 26 | TECH | Bio-Techne Corporation | 8.55B | -0.62% | 152,285 | 1.22B |
| 27 | PCVX | Vaxcyte, Inc. | 8.31B | 1.05% | 82,995 | - |
| 28 | CYTK | Cytokinetics, Incorporated | 8.04B | 2.21% | 269,577 | 88.04M |
| 29 | NUVL | Nuvalent, Inc. | 7.97B | 2.38% | 86,305 | - |
| 30 | KRYS | Krystal Biotech, Inc. | 7.87B | 0.55% | 190,177 | 417.30M |
| 31 | IBRX | ImmunityBio, Inc. | 7.70B | 4.92% | 3,287,132 | 113.29M |
| 32 | HALO | Halozyme Therapeutics, Inc. | 7.64B | 0.80% | 88,781 | 1.40B |
| 33 | CELC | Celcuity Inc. | 7.07B | 16.46% | 1,034,116 | - |
| 34 | KYMR | Kymera Therapeutics, Inc. | 6.80B | 2.35% | 44,736 | 51.48M |
| 35 | MIRM | Mirum Pharmaceuticals, Inc. | 6.47B | 9.85% | 374,737 | 521.31M |
| 36 | PTGX | Protagonist Therapeutics, Inc. | 6.41B | 2.10% | 34,329 | 46.02M |
| 37 | APGE | Apogee Therapeutics, Inc. | 6.30B | 4.48% | 97,206 | - |
| 38 | COGT | Cogent Biosciences, Inc. | 6.30B | 0.60% | 160,134 | - |
| 39 | BLTE | Belite Bio, Inc | 6.18B | 1.47% | 5,403 | - |
| 40 | CNTA | Centessa Pharmaceuticals plc | 6.13B | 0.18% | 66,176 | 15.00M |
| 41 | TERN | Terns Pharmaceuticals, Inc. | 6.12B | 0.09% | 621,879 | - |
| 42 | SYRE | Spyre Therapeutics, Inc. | 6.05B | 1.09% | 175,380 | - |
| 43 | CGON | CG Oncology, Inc. | 5.90B | 1.19% | 47,128 | 4.04M |
| 44 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.66B | 1.26% | 81,522 | 189.76M |
| 45 | SRRK | Scholar Rock Holding Corporation | 5.57B | 0.75% | 64,906 | - |
| 46 | XENE | Xenon Pharmaceuticals Inc. | 5.56B | 2.42% | 178,051 | 7.50M |
| 47 | IMVT | Immunovant, Inc. | 5.55B | 0.48% | 62,528 | - |
| 48 | CORT | Corcept Therapeutics Incorporated | 5.50B | -0.43% | 138,430 | 769.10M |
| 49 | PTCT | PTC Therapeutics, Inc. | 5.37B | -0.64% | 119,018 | 1.73B |
| 50 | APLS | Apellis Pharmaceuticals, Inc. | 5.24B | - | 696,434 | 1.00B |
| 51 | CAI | Caris Life Sciences, Inc. | 5.21B | -0.22% | 172,363 | 812.03M |
| 52 | CRSP | CRISPR Therapeutics AG | 5.14B | 3.39% | 210,983 | 3.51M |
| 53 | TGTX | TG Therapeutics, Inc. | 5.13B | 2.66% | 213,030 | 616.29M |
| 54 | DNTH | Dianthus Therapeutics, Inc. | 4.90B | 2.89% | 43,361 | 2.04M |
| 55 | LGND | Ligand Pharmaceuticals Incorporated | 4.63B | 1.69% | 38,843 | 268.09M |
| 56 | LEGN | Legend Biotech Corporation | 4.49B | 3.01% | 226,179 | 1.03B |
| 57 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.21B | 2.97% | 136,379 | 7.70M |
| 58 | TVTX | Travere Therapeutics, Inc. | 4.16B | 2.06% | 277,037 | 490.73M |
| 59 | TLX | Telix Pharmaceuticals Limited | 3.82B | -0.27% | 14,013 | 803.79M |
| 60 | ACAD | ACADIA Pharmaceuticals Inc. | 3.80B | 1.03% | 200,220 | 1.07B |
| 61 | MANE | Veradermics, Incorporated | 3.76B | -0.23% | 72,667 | - |
| 62 | ORKA | Oruka Therapeutics, Inc. | 3.71B | -1.04% | 330,857 | - |
| 63 | VKTX | Viking Therapeutics, Inc. | 3.61B | 3.77% | 616,083 | - |
| 64 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.56B | 1.57% | 129,349 | 588.99M |
| 65 | EWTX | Edgewise Therapeutics, Inc. | 3.34B | 1.60% | 59,610 | - |
| 66 | ALMS | Alumis Inc. | 3.34B | 4.29% | 163,087 | 24.05M |
| 67 | NAMS | NewAmsterdam Pharma Company N.V. | 3.33B | 1.90% | 72,918 | 22.50M |
| 68 | RCUS | Arcus Biosciences, Inc. | 3.24B | 0.41% | 84,813 | 247.00M |
| 69 | KLRA | Kailera Therapeutics, Inc. | 3.21B | -1.39% | 94,102 | - |
| 70 | TNGX | Tango Therapeutics, Inc. | 3.21B | 5.96% | 391,686 | 62.38M |
| 71 | BEAM | Beam Therapeutics Inc. | 3.13B | 1.79% | 226,185 | 139.74M |
| 72 | ERAS | Erasca, Inc. | 3.10B | -0.50% | 926,224 | - |
| 73 | GPCR | Structure Therapeutics Inc. | 3.04B | 1.35% | 118,933 | - |
| 74 | ARQT | Arcutis Biotherapeutics, Inc. | 2.97B | 1.65% | 144,456 | 376.07M |
| 75 | DNLI | Denali Therapeutics Inc. | 2.96B | 2.05% | 305,499 | - |
| 76 | NKTR | Nektar Therapeutics | 2.94B | 0.67% | 114,382 | 55.23M |
| 77 | DYN | Dyne Therapeutics, Inc. | 2.89B | 0.69% | 252,322 | - |
| 78 | KOD | Kodiak Sciences Inc. | 2.85B | 4.55% | 161,325 | - |
| 79 | TARS | Tarsus Pharmaceuticals, Inc. | 2.74B | 1.11% | 41,888 | 451.36M |
| 80 | SLNO | Soleno Therapeutics, Inc. | 2.73B | 0.02% | 161,690 | 190.41M |
| 81 | IMNM | Immunome, Inc. | 2.62B | 1.65% | 64,430 | 6.94M |
| 82 | VERA | Vera Therapeutics, Inc. | 2.59B | 2.50% | 193,007 | - |
| 83 | IRON | Disc Medicine, Inc. | 2.58B | 1.00% | 49,690 | - |
| 84 | CLDX | Celldex Therapeutics, Inc. | 2.56B | 1.08% | 47,950 | 1.55M |
| 85 | IDYA | IDEAYA Biosciences, Inc. | 2.51B | 1.42% | 184,738 | 218.71M |
| 86 | ELVN | Enliven Therapeutics, Inc. | 2.48B | -0.74% | 43,256 | - |
| 87 | RARE | Ultragenyx Pharmaceutical Inc. | 2.45B | 0.61% | 139,349 | 673.00M |
| 88 | ADMA | ADMA Biologics, Inc. | 2.43B | -0.57% | 874,215 | 510.17M |
| 89 | ZLAB | Zai Lab Limited | 2.39B | -1.39% | 43,044 | 460.16M |
| 90 | RLAY | Relay Therapeutics, Inc. | 2.34B | -2.59% | 583,078 | 15.36M |
| 91 | SRPT | Sarepta Therapeutics, Inc. | 2.33B | 2.84% | 690,606 | 2.20B |
| 92 | MLYS | Mineralys Therapeutics, Inc. | 2.33B | -3.35% | 145,168 | - |
| 93 | ADPT | Adaptive Biotechnologies Corporation | 2.33B | 2.10% | 203,492 | 276.98M |
| 94 | DFTX | Definium Therapeutics, Inc. | 2.17B | 0.41% | 227,533 | - |
| 95 | STOK | Stoke Therapeutics, Inc. | 2.12B | 2.87% | 63,634 | 184.42M |
| 96 | OCUL | Ocular Therapeutix, Inc. | 2.09B | 1.80% | 265,848 | 51.95M |
| 97 | TYRA | Tyra Biosciences, Inc. | 2.08B | 2.86% | 134,780 | - |
| 98 | MESO | Mesoblast Limited | 2.06B | 0.51% | 27,883 | 65.38M |
| 99 | AUPH | Aurinia Pharmaceuticals Inc. | 2.04B | 2.15% | 237,171 | 283.06M |
| 100 | AAPG | Ascentage Pharma Group International | 2.03B | -5.53% | 629 | 82.08M |
| 101 | TRVI | Trevi Therapeutics, Inc. | 2.03B | 4.54% | 430,134 | - |
| 102 | ANAB | AnaptysBio, Inc. | 1.99B | 3.48% | 45,674 | 234.60M |
| 103 | ZYME | Zymeworks Inc. | 1.98B | 0.86% | 43,364 | 105.97M |
| 104 | PHVS | Pharvaris N.V. | 1.93B | 0.31% | 23,251 | - |
| 105 | INBX | Inhibrx Biosciences, Inc. | 1.92B | 2.24% | 38,716 | 1.30M |
| 106 | HRMY | Harmony Biosciences Holdings, Inc. | 1.89B | 2.58% | 66,514 | 868.45M |
| 107 | CAPR | Capricor Therapeutics, Inc. | 1.87B | 4.66% | 154,789 | 11.13M |
| 108 | GLPG | Galapagos NV | 1.87B | 0.82% | 134,643 | 1.31B |
| 109 | PVLA | Palvella Therapeutics, Inc. | 1.84B | 1.36% | 21,435 | - |
| 110 | VCEL | Vericel Corporation | 1.84B | 1.55% | 31,352 | 276.26M |
| 111 | TSHA | Taysha Gene Therapies, Inc. | 1.84B | 1.03% | 163,740 | 9.77M |
| 112 | SION | Sionna Therapeutics, Inc. | 1.83B | 3.78% | 41,624 | - |
| 113 | RXRX | Recursion Pharmaceuticals, Inc. | 1.82B | 1.77% | 2,381,977 | 74.68M |
| 114 | SNDX | Syndax Pharmaceuticals, Inc. | 1.78B | 5.10% | 346,477 | 217.17M |
| 115 | NRIX | Nurix Therapeutics, Inc. | 1.75B | 0.71% | 59,134 | 71.78M |
| 116 | ARDX | Ardelyx, Inc. | 1.74B | 2.54% | 2,264,494 | 427.68M |
| 117 | INVA | Innoviva, Inc. | 1.72B | 0.48% | 31,838 | 411.33M |
| 118 | RAPP | Rapport Therapeutics, Inc. | 1.71B | 5.49% | 59,915 | - |
| 119 | GENB | Generate Biomedicines, Inc. | 1.70B | 1.67% | 30,212 | 31.89M |
| 120 | AGIO | Agios Pharmaceuticals, Inc. | 1.64B | -1.78% | 148,999 | 66.05M |
| 121 | VIR | Vir Biotechnology, Inc. | 1.64B | 1.50% | 94,971 | 68.56M |
| 122 | NBTX | Nanobiotix S.A. | 1.63B | -10.11% | 44,994 | 38.27M |
| 123 | OCS | Oculis Holding AG | 1.63B | 0.47% | 15,603 | 1.51M |
| 124 | NUVB | Nuvation Bio Inc. | 1.62B | 4.01% | 682,934 | 62.90M |
| 125 | NTLA | Intellia Therapeutics, Inc. | 1.60B | 2.11% | 1,578,724 | 67.67M |
| 126 | DMRA | Damora Therapeutics, Inc. | 1.58B | 3.08% | 28,341 | - |
| 127 | BHVN | Biohaven Ltd. | 1.54B | 6.33% | 313,012 | - |
| 128 | GLUE | Monte Rosa Therapeutics, Inc. | 1.54B | 2.18% | 66,986 | 123.67M |
| 129 | MAZE | Maze Therapeutics, Inc. | 1.51B | 0.81% | 70,526 | 2.50M |
| 130 | IOVA | Iovance Biotherapeutics, Inc. | 1.51B | 7.79% | 4,651,915 | 263.50M |
| 131 | ATAI | AtaiBeckley Inc. | 1.49B | -1.93% | 559,074 | 4.09M |
| 132 | BCAX | Bicara Therapeutics Inc. | 1.46B | 2.95% | 12,132 | - |
| 133 | VRDN | Viridian Therapeutics, Inc. | 1.45B | 5.07% | 170,799 | 70.85M |
| 134 | IMCR | Immunocore Holdings plc | 1.45B | 1.10% | 57,179 | 400.02M |
| 135 | PGEN | Precigen, Inc. | 1.43B | -0.74% | 400,087 | 9.68M |
| 136 | IMTX | Immatics N.V. | 1.43B | -1.20% | 17,318 | 56.67M |
| 137 | WVE | Wave Life Sciences Ltd. | 1.42B | 0.68% | 410,509 | 71.80M |
| 138 | ABCL | AbCellera Biologics Inc. | 1.41B | 4.85% | 1,888,920 | 75.13M |
| 139 | MBX | MBX Biosciences, Inc. | 1.40B | -1.11% | 66,749 | - |
| 140 | KALV | KalVista Pharmaceuticals, Inc. | 1.37B | 0.04% | 1,135,874 | 73.62M |
| 141 | NVAX | Novavax, Inc. | 1.36B | 3.61% | 801,839 | 1.12B |
| 142 | AVBP | ArriVent BioPharma, Inc. | 1.36B | 2.30% | 44,811 | - |
| 143 | SVRA | Savara Inc. | 1.35B | 3.71% | 154,743 | - |
| 144 | CRVS | Corvus Pharmaceuticals, Inc. | 1.34B | 2.81% | 137,840 | - |
| 145 | MPLT | MapLight Therapeutics, Inc. | 1.33B | -4.14% | 24,559 | - |
| 146 | COAG | Hemab Therapeutics Holdings, Inc. | 1.31B | -12.49% | 212,654 | - |
| 147 | GHRS | GH Research PLC | 1.28B | -0.53% | 33,904 | - |
| 148 | OLMA | Olema Pharmaceuticals, Inc. | 1.28B | 2.23% | 107,189 | - |
| 149 | QURE | uniQure N.V. | 1.27B | 4.97% | 333,289 | 16.10M |
| 150 | DBVT | DBV Technologies S.A. | 1.26B | -0.96% | 63,411 | 5.74M |
| 151 | MLTX | MoonLake Immunotherapeutics | 1.26B | 4.72% | 144,628 | - |
| 152 | JBIO | Jade Biosciences, Inc. | 1.23B | 2.60% | 46,425 | - |
| 153 | ZBIO | Zenas BioPharma, Inc. | 1.22B | 6.25% | 85,695 | 10.00M |
| 154 | AVLN | Avalyn Pharma Inc. | 1.21B | -2.87% | 30,486 | - |
| 155 | PHAR | Pharming Group N.V. | 1.19B | -1.15% | 3,228 | 376.13M |
| 156 | FTRE | Fortrea Holdings Inc. | 1.15B | -0.08% | 293,307 | 2.72B |
| 157 | EYPT | EyePoint, Inc. | 1.14B | 2.36% | 98,204 | 31.37M |
| 158 | URGN | UroGen Pharma Ltd. | 1.14B | 1.43% | 107,613 | 109.79M |
| 159 | XERS | Xeris Biopharma Holdings, Inc. | 1.10B | 1.75% | 219,158 | 291.85M |
| 160 | SEPN | Septerna, Inc. | 1.10B | 3.92% | 23,329 | 45.95M |
| 161 | AKTS | Aktis Oncology, Inc. | 1.10B | 2.37% | 8,071 | 6.50M |
| 162 | OMER | Omeros Corporation | 1.08B | -0.13% | 232,332 | - |
| 163 | IVA | Inventiva S.A. | 1.05B | 3.72% | 29,049 | 7.94M |
| 164 | GERN | Geron Corporation | 1.02B | 0.32% | 1,453,069 | 183.88M |
| 165 | ORIC | ORIC Pharmaceuticals, Inc. | 982.51M | 0.20% | 142,194 | - |
| 166 | XNCR | Xencor, Inc. | 973.94M | 4.65% | 338,455 | 125.58M |
| 167 | MRVI | Maravai LifeSciences Holdings, Inc. | 951.39M | -1.21% | 49,805 | 185.74M |
| 168 | SLS | SELLAS Life Sciences Group, Inc. | 949.42M | 4.36% | 1,115,128 | - |
| 169 | ANNX | Annexon, Inc. | 945.79M | 1.22% | 300,808 | - |
| 170 | PHAT | Phathom Pharmaceuticals, Inc. | 939.66M | -1.50% | 146,754 | 204.89M |
| 171 | CTMX | CytomX Therapeutics, Inc. | 928.46M | 2.03% | 428,280 | 76.20M |
| 172 | SPTX | Seaport Therapeutics, Inc. | 927.99M | -11.79% | 188,715 | - |
| 173 | LBRX | LB Pharmaceuticals Inc | 904.86M | 0.40% | 5,074 | - |
| 174 | MGTX | MeiraGTx Holdings plc | 904.75M | 3.88% | 41,624 | 81.39M |
| 175 | SANA | Sana Biotechnology, Inc. | 893.67M | 1.22% | 220,865 | - |
| 176 | ANRO | Alto Neuroscience, Inc. | 890.69M | 1.88% | 16,822 | - |
| 177 | JANX | Janux Therapeutics, Inc. | 881.45M | 1.05% | 84,995 | 10.00M |
| 178 | EVMN | Evommune, Inc. | 873.45M | -1.02% | 119,298 | 13.00M |
| 179 | CGEM | Cullinan Therapeutics, Inc. | 872.18M | 7.30% | 434,007 | - |
| 180 | SPRY | ARS Pharmaceuticals, Inc. | 870.84M | 2.45% | 137,977 | 84.28M |
| 181 | MNKD | MannKind Corporation | 869.26M | -0.88% | 652,166 | 348.97M |
| 182 | TBPH | Theravance Biopharma, Inc. | 867.14M | 0.30% | 39,295 | 107.46M |
| 183 | ABUS | Arbutus Biopharma Corporation | 860.63M | 1.16% | 87,469 | 14.08M |
| 184 | DRUG | Bright Minds Biosciences Inc. | 856.77M | -0.48% | 30,429 | - |
| 185 | DSGN | Design Therapeutics, Inc. | 840.05M | 1.13% | 82,632 | - |
| 186 | SGP | SpyGlass Pharma, Inc. | 820.45M | 2.36% | 6,504 | - |
| 187 | KURA | Kura Oncology, Inc. | 811.29M | 4.22% | 164,723 | 67.48M |
| 188 | RLMD | Relmada Therapeutics, Inc. | 809.74M | 1.05% | 83,132 | - |
| 189 | TENX | Tenax Therapeutics, Inc. | 781.90M | 3.91% | 55,676 | - |
| 190 | ABSI | Absci Corporation | 772.57M | 1.02% | 449,155 | 2.80M |
| 191 | TRAX | First Tracks Biotherapeutics, Inc. | 763.78M | -1.79% | 313,530 | - |
| 192 | VOR | Vor Biopharma Inc. | 754.26M | 0.51% | 104,772 | - |
| 193 | ALLO | Allogene Therapeutics, Inc. | 746.43M | 0.93% | 550,552 | 22.00K |
| 194 | SLDB | Solid Biosciences Inc. | 732.69M | 4.42% | 73,335 | - |
| 195 | FBRX | Forte Biosciences, Inc. | 730.92M | 5.92% | 46,866 | - |
| 196 | GYRE | Gyre Therapeutics, Inc. | 730.51M | 2.56% | 12,801 | 116.59M |
| 197 | DRTS | Alpha Tau Medical Ltd. | 730.48M | -2.81% | 551,028 | - |
| 198 | LXRX | Lexicon Pharmaceuticals, Inc. | 697.84M | 1.05% | 291,221 | 49.80M |
| 199 | ARVN | Arvinas, Inc. | 693.98M | 3.24% | 490,024 | 262.60M |
| 200 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 673.48M | 0.30% | 46,331 | - |
| 201 | OCGN | Ocugen, Inc. | 638.10M | 4.72% | 1,610,753 | 4.41M |
| 202 | ACRS | Aclaris Therapeutics, Inc. | 631.28M | 2.49% | 126,643 | 7.83M |
| 203 | CBIO | Crescent Biopharma, Inc. | 624.37M | 3.98% | 41,265 | 11.88M |
| 204 | CRMD | CorMedix Inc. | 620.37M | 1.54% | 274,017 | 311.71M |
| 205 | PRME | Prime Medicine, Inc. | 614.69M | 1.76% | 229,282 | 4.63M |
| 206 | ZVRA | Zevra Therapeutics, Inc. | 610.66M | 2.58% | 78,431 | 106.47M |
| 207 | STRO | Sutro Biopharma, Inc. | 606.80M | 2.91% | 11,430 | 102.48M |
| 208 | PROK | ProKidney Corp. | 596.37M | 2.33% | 51,415 | 893.00K |
| 209 | ANL | Adlai Nortye Ltd. | 588.40M | -5.10% | 15,180 | 5.00M |
| 210 | DNA | Ginkgo Bioworks Holdings, Inc. | 585.86M | 3.76% | 518,188 | 170.16M |
| 211 | PRTA | Prothena Corporation plc | 584.09M | 1.97% | 44,882 | 9.68M |
| 212 | ALT | Altimmune, Inc. | 576.77M | 5.32% | 1,409,795 | 41.00K |
| 213 | TECX | Tectonic Therapeutic, Inc. | 565.46M | 3.23% | 13,686 | - |
| 214 | TRDA | Entrada Therapeutics, Inc. | 561.93M | 6.07% | 41,476 | 25.42M |
| 215 | RIGL | Rigel Pharmaceuticals, Inc. | 554.40M | 2.04% | 70,988 | 294.28M |
| 216 | EIKN | Eikon Therapeutics, Inc. | 544.09M | 3.82% | 55,863 | - |
| 217 | MDXG | MiMedx Group, Inc. | 542.16M | -1.09% | 271,366 | 389.42M |
| 218 | STTK | Shattuck Labs, Inc. | 540.03M | 2.22% | 96,383 | 1.00M |
| 219 | AURA | Aura Biosciences, Inc. | 536.71M | 19.26% | 547,834 | - |
| 220 | AGMB | AgomAb Therapeutics NV | 536.35M | -1.65% | 954 | - |
| 221 | KYTX | Kyverna Therapeutics, Inc. | 532.06M | -0.90% | 140,711 | - |
| 222 | VSTM | Verastem, Inc. | 517.39M | 0.86% | 235,665 | 30.91M |
| 223 | UPB | Upstream Bio, Inc. | 514.81M | 0.64% | 35,963 | 2.85M |
| 224 | VALN | Valneva SE | 514.39M | -3.93% | 11,437 | 205.07M |
| 225 | OVID | Ovid Therapeutics Inc. | 507.00M | 5.02% | 286,909 | 7.25M |
| 226 | ZURA | Zura Bio Limited | 505.24M | 2.21% | 26,010 | - |
| 227 | FULC | Fulcrum Therapeutics, Inc. | 503.75M | 2.72% | 26,536 | 80.00M |
| 228 | CADL | Candel Therapeutics, Inc. | 503.21M | 6.18% | 442,918 | - |
| 229 | CTNM | Contineum Therapeutics, Inc. | 500.30M | 1.52% | 134,279 | - |
| 230 | IMMX | Immix Biopharma, Inc. | 496.46M | 0.70% | 184,573 | - |
| 231 | XOMA | XOMA Royalty Corporation | 494.98M | 0.39% | 21,611 | 52.15M |
| 232 | ENGN | enGene Therapeutics Inc. | 494.38M | 1.79% | 28,012 | - |
| 233 | LYEL | Lyell Immunopharma, Inc. | 492.78M | 1.39% | 6,292 | 36.00K |
| 234 | EPRX | Eupraxia Pharmaceuticals Inc. | 487.15M | -0.54% | 10,555 | - |
| 235 | ADCT | ADC Therapeutics SA | 483.96M | -0.65% | 272,649 | 79.18M |
| 236 | PRLD | Prelude Therapeutics Incorporated | 483.66M | 2.34% | 77,697 | 12.14M |
| 237 | SGMT | Sagimet Biosciences Inc. | 482.28M | 2.63% | 162,558 | - |
| 238 | FDMT | 4D Molecular Therapeutics, Inc. | 477.33M | 2.86% | 135,270 | 85.21M |
| 239 | RGNX | REGENXBIO Inc. | 473.85M | 0.66% | 53,552 | 170.44M |
| 240 | PRTC | PureTech Health plc | 460.34M | -4.80% | 8,027 | 4.66M |
| 241 | CLYM | Climb Bio, Inc. | 452.37M | 6.29% | 95,908 | - |
| 242 | AVIR | Atea Pharmaceuticals, Inc. | 451.74M | 1.61% | 35,712 | - |
| 243 | VNDA | Vanda Pharmaceuticals Inc. | 443.20M | 5.29% | 470,250 | 216.11M |
| 244 | NMRA | Neumora Therapeutics, Inc. | 443.02M | -0.61% | 117,769 | - |
| 245 | ASMB | Assembly Biosciences, Inc. | 436.65M | 0.38% | 4,201 | 72.30M |
| 246 | IVVD | Invivyd, Inc. | 434.10M | 0.99% | 273,353 | 53.43M |
| 247 | LXEO | Lexeo Therapeutics, Inc. | 433.04M | 1.30% | 49,604 | - |
| 248 | NGNE | Neurogene Inc. | 430.21M | 2.61% | 10,849 | 925.00K |
| 249 | LRMR | Larimar Therapeutics, Inc. | 429.04M | 4.82% | 246,971 | - |
| 250 | ENTA | Enanta Pharmaceuticals, Inc. | 422.23M | 1.39% | 23,906 | 66.98M |
| 251 | IPSC | Century Therapeutics, Inc. | 414.13M | -0.43% | 104,613 | 109.16M |
| 252 | BNTC | Benitec Biopharma Inc. | 410.37M | 0.25% | 8,170 | - |
| 253 | NAGE | Niagen Bioscience, Inc. | 405.25M | 4.12% | 167,255 | 129.42M |
| 254 | AUTL | Autolus Therapeutics plc | 396.55M | 1.36% | 184,707 | 75.39M |
| 255 | VTVT | vTv Therapeutics Inc. | 395.86M | 0.68% | 3,364 | 17.00K |
| 256 | RCKT | Rocket Pharmaceuticals, Inc. | 395.02M | 1.69% | 206,548 | - |
| 257 | SRZN | Surrozen, Inc. | 390.55M | 1.19% | 9,608 | 3.48M |
| 258 | XFOR | X4 Pharmaceuticals, Inc. | 385.50M | 1.19% | 34,912 | 35.11M |
| 259 | PBYI | Puma Biotechnology, Inc. | 384.63M | 0.93% | 88,477 | 228.37M |
| 260 | IRD | Opus Genetics, Inc. | 377.01M | 2.72% | 169,890 | 14.20M |
| 261 | AVTX | Avalo Therapeutics, Inc. | 375.74M | 2.59% | 49,988 | 59.00K |
| 262 | CABA | Cabaletta Bio, Inc. | 374.04M | 14.29% | 8,941,952 | - |
| 263 | LCTX | Lineage Cell Therapeutics, Inc. | 369.89M | -2.94% | 396,378 | 14.56M |
| 264 | ARMP | Armata Pharmaceuticals, Inc. | 369.62M | 13.50% | 28,112 | 4.90M |
| 265 | RZLT | Rezolute, Inc. | 362.51M | 5.76% | 365,948 | - |
| 266 | NAUT | Nautilus Biotechnology, Inc. | 361.97M | 5.93% | 92,276 | - |
| 267 | MNPR | Monopar Therapeutics Inc. | 358.63M | 0.64% | 8,428 | - |
| 268 | IMRX | Immuneering Corporation | 351.31M | 1.12% | 83,795 | - |
| 269 | CMPX | Compass Therapeutics, Inc. | 349.37M | -1.02% | 3,738,405 | 850.00K |
| 270 | DMAC | DiaMedica Therapeutics Inc. | 347.00M | 4.21% | 10,731 | - |
| 271 | SLN | Silence Therapeutics plc | 342.92M | 1.82% | 3,689 | 559.00K |
| 272 | YDES | YD Bio Limited | 341.75M | 1.25% | 4,559 | 510.36K |
| 273 | BCYC | Bicycle Therapeutics plc | 340.17M | 1.67% | 42,400 | 63.50M |
| 274 | PALI | Palisade Bio, Inc. | 339.03M | 1.76% | 273,054 | - |
| 275 | IKT | Inhibikase Therapeutics, Inc. | 334.09M | 2.62% | 55,029 | 1.00 |
| 276 | ABEO | Abeona Therapeutics Inc. | 328.78M | 6.45% | 244,437 | 5.82M |
| 277 | GLSI | Greenwich LifeSciences, Inc. | 322.81M | -1.69% | 25,656 | - |
| 278 | AVXL | Anavex Life Sciences Corp. | 321.11M | 4.37% | 140,982 | - |
| 279 | ZNTL | Zentalis Pharmaceuticals, Inc. | 304.29M | 4.89% | 241,583 | 26.87M |
| 280 | NGEN | NervGen Pharma Corp. | 300.25M | -1.85% | 20,789 | - |
| 281 | ACIU | AC Immune SA | 299.59M | 1.34% | 56,306 | 4.62M |
| 282 | EDIT | Editas Medicine, Inc. | 297.04M | 4.66% | 214,704 | 40.52M |
| 283 | TARA | Protara Therapeutics, Inc. | 296.92M | 3.20% | 149,297 | - |
| 284 | LENZ | LENZ Therapeutics, Inc. | 294.73M | 5.86% | 276,730 | 19.09M |
| 285 | ELDN | Eledon Pharmaceuticals, Inc. | 291.71M | 4.07% | 164,866 | - |
| 286 | CCCC | C4 Therapeutics, Inc. | 285.90M | 0.34% | 234,298 | 35.95M |
| 287 | FHTX | Foghorn Therapeutics Inc. | 285.28M | 2.10% | 9,854 | 30.91M |
| 288 | CLLS | Cellectis S.A. | 283.24M | -1.77% | 1,033 | 79.59M |
| 289 | CHRS | Coherus Oncology, Inc. | 278.36M | 0.28% | 64,069 | 42.17M |
| 290 | NERV | Minerva Neurosciences, Inc. | 278.18M | 4.53% | 6,863 | - |
| 291 | NBP | NovaBridge Biosciences | 275.82M | 0.21% | 344,927 | - |
| 292 | ARTV | Artiva Biotherapeutics, Inc. | 272.87M | 2.22% | 25,354 | 251.00K |
| 293 | ALEC | Alector, Inc. | 270.39M | 3.81% | 54,701 | 21.05M |
| 294 | HELP | Cybin Inc. | 262.69M | 1.94% | 176,596 | - |
| 295 | SLGL | Sol-Gel Technologies Ltd. | 252.53M | 2.17% | 3,573 | 19.39M |
| 296 | CGEN | Compugen Ltd. | 252.46M | -1.48% | 105,035 | 72.76M |
| 297 | SABS | SAB Biotherapeutics, Inc. | 252.29M | 3.46% | 29,883 | 114.70K |
| 298 | ARCT | Arcturus Therapeutics Holdings Inc. | 250.12M | 1.97% | 58,781 | 82.03M |
| 299 | ADAG | Adagene Inc. | 246.46M | -2.35% | 27,038 | 7.67M |
| 300 | CDXS | Codexis, Inc. | 244.44M | 0.75% | 188,977 | 70.39M |
| 301 | REPL | Replimune Group, Inc. | 244.41M | 18.40% | 1,687,549 | - |
| 302 | ALXO | ALX Oncology Holdings Inc. | 242.21M | 6.51% | 171,571 | - |
| 303 | HRTX | Heron Therapeutics, Inc. | 241.21M | 0.69% | 351,259 | 154.90M |
| 304 | OBIO | Orchestra BioMed Holdings, Inc. | 241.11M | 3.78% | 21,992 | 33.48M |
| 305 | PLYX | Polaryx Therapeutics, Inc. | 238.69M | 3.31% | 13,355 | - |
| 306 | ACHV | Achieve Life Sciences, Inc. | 237.98M | 2.05% | 111,499 | - |
| 307 | KROS | Keros Therapeutics, Inc. | 236.66M | 4.09% | 45,518 | 244.06M |
| 308 | MIST | Milestone Pharmaceuticals Inc. | 235.49M | 2.67% | 230,141 | 1.55M |
| 309 | FENC | Fennec Pharmaceuticals Inc. | 234.95M | 4.20% | 8,354 | 44.64M |
| 310 | VYGR | Voyager Therapeutics, Inc. | 230.65M | 2.93% | 67,908 | 40.37M |
| 311 | NVCT | Nuvectis Pharma, Inc. | 229.15M | 1.29% | 2,833 | - |
| 312 | MDWD | MediWound Ltd. | 216.82M | 1.44% | 2,475 | 16.96M |
| 313 | CAMP | Camp4 Therapeutics Corporation | 216.27M | 2.84% | 3,407 | 3.50M |
| 314 | CNTX | Context Therapeutics Inc. | 214.54M | 2.86% | 88,414 | - |
| 315 | NKTX | Nkarta, Inc. | 210.31M | 0.68% | 97,276 | - |
| 316 | KPTI | Karyopharm Therapeutics Inc. | 209.65M | 6.04% | 65,047 | 146.07M |
| 317 | OABI | OmniAb, Inc. | 208.49M | 2.86% | 15,238 | 18.67M |
| 318 | RNA | Atrium Therapeutics, Inc. | 207.44M | -0.45% | 53,088 | 18.62M |
| 319 | MGNX | MacroGenics, Inc. | 207.21M | 4.15% | 136,284 | 149.50M |
| 320 | HUMA | Humacyte, Inc. | 206.03M | 8.50% | 1,473,342 | 2.04M |
| 321 | ENLV | Enlivex Ltd. | 201.61M | 2.50% | 93,531 | - |
| 322 | FATE | Fate Therapeutics, Inc. | 198.84M | 11.76% | 2,308,935 | 6.65M |
| 323 | ELTX | Elicio Therapeutics, Inc. | 198.68M | 0.47% | 14,161 | - |
| 324 | RNAC | Cartesian Therapeutics, Inc. | 198.62M | 8.68% | 28,518 | 1.78M |
| 325 | UNCY | Unicycive Therapeutics, Inc. | 197.61M | 2.09% | 128,573 | - |
| 326 | DTIL | Precision BioSciences, Inc. | 194.81M | 3.71% | 19,446 | 34.26M |
| 327 | WHWK | Whitehawk Therapeutics, Inc. | 194.45M | 3.26% | 9,451 | 7.15M |
| 328 | KRRO | Korro Bio, Inc. | 193.91M | -0.92% | 6,817 | 6.39M |
| 329 | OKUR | OnKure Therapeutics, Inc. | 190.46M | -0.32% | 26,730 | - |
| 330 | CRBU | Caribou Biosciences, Inc. | 189.64M | 3.21% | 275,646 | 11.16M |
| 331 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 186.85M | 2.28% | 84,989 | - |
| 332 | TNXP | Tonix Pharmaceuticals Holding Corp. | 186.37M | -3.53% | 228,872 | 13.11M |
| 333 | CNTN | Canton Strategic Holdings, Inc. | 181.30M | -0.93% | 93,338 | - |
| 334 | TLSA | Tiziana Life Sciences Ltd | 178.67M | 4.48% | 41,486 | - |
| 335 | ABOS | Acumen Pharmaceuticals, Inc. | 172.99M | 0.63% | 80,318 | - |
| 336 | MENS | Jyong Biotech Ltd. | 172.26M | -0.44% | 19,764 | - |
| 337 | PLX | Protalix BioTherapeutics, Inc. | 171.21M | 0.24% | 99,343 | 52.74M |
| 338 | ANTX | AN2 Therapeutics, Inc. | 169.90M | 0.86% | 20,073 | - |
| 339 | PRQR | ProQR Therapeutics N.V. | 168.58M | 3.23% | 159,658 | 19.19M |
| 340 | TNYA | Tenaya Therapeutics, Inc. | 165.79M | 8.25% | 1,787,595 | - |
| 341 | ORMP | Oramed Pharmaceuticals Inc. | 161.58M | 0.38% | 14,540 | 2.00M |
| 342 | EDSA | Edesa Biotech, Inc. | 159.23M | 1.88% | 197,757 | - |
| 343 | KZIA | Kazia Therapeutics Limited | 156.95M | 2.58% | 64,373 | 1.27M |
| 344 | SPRB | Spruce Biosciences, Inc. | 155.79M | 0.65% | 4,975 | 697.00K |
| 345 | IFRX | InflaRx N.V. | 155.43M | 2.38% | 215,056 | 34.44K |
| 346 | BDTX | Black Diamond Therapeutics, Inc. | 155.25M | 4.23% | 246,162 | 70.00M |
| 347 | MOLN | Molecular Partners AG | 153.58M | 0.92% | 140 | 856.30K |
| 348 | ALPS | Alps Group Inc | 153.09M | 1.11% | 1,148 | 3.74M |
| 349 | GALT | Galectin Therapeutics Inc. | 150.38M | 0.64% | 30,589 | - |
| 350 | AGEN | Agenus Inc. | 146.30M | -0.78% | 156,217 | 114.20M |
| 351 | SPRO | Spero Therapeutics, Inc. | 145.02M | 1.01% | 138,653 | 66.80M |
| 352 | HURA | TuHURA Biosciences, Inc. | 141.14M | -4.72% | 227,612 | - |
| 353 | CNTB | Connect Biopharma Holdings Limited | 139.72M | 0.08% | 3,736 | 64.00K |
| 354 | IMUX | Immunic, Inc. | 136.20M | 3.78% | 54,118 | - |
| 355 | EQ | Equillium, Inc. | 132.72M | 0.92% | 50,256 | 4.39M |
| 356 | IPHA | Innate Pharma S.A. | 132.09M | 8.33% | 8,335 | 10.57M |
| 357 | ACOG | Alpha Cognition Inc. | 130.43M | 0.67% | 6,968 | 10.22M |
| 358 | KLRS | Kalaris Therapeutics, Inc. | 126.57M | 0.82% | 9,079 | - |
| 359 | GNLX | Genelux Corporation | 122.92M | 1.10% | 36,286 | 8.00K |
| 360 | PEPG | PepGen Inc. | 121.64M | 0.57% | 295,046 | - |
| 361 | AARD | Aardvark Therapeutics, Inc. | 120.42M | 1.10% | 28,874 | - |
| 362 | CGTX | Cognition Therapeutics, Inc. | 118.84M | 3.91% | 259,702 | - |
| 363 | GUTS | Fractyl Health, Inc. | 118.51M | 6.82% | 579,652 | 3.00K |
| 364 | VANI | Vivani Medical, Inc. | 115.97M | 0.74% | 60,578 | - |
| 365 | SEER | Seer, Inc. | 115.66M | 0.99% | 236,236 | 16.58M |
| 366 | CRDF | Cardiff Oncology, Inc. | 115.20M | -1.46% | 96,118 | 593.00K |
| 367 | TTRX | Turn Therapeutics Inc. | 113.19M | - | 9,594 | - |
| 368 | PYXS | Pyxis Oncology, Inc. | 113.09M | 4.65% | 44,829 | 13.86M |
| 369 | ONCY | Oncolytics Biotech Inc. | 109.15M | 8.02% | 568,498 | - |
| 370 | CBUS | Cibus, Inc. | 108.32M | -2.07% | 11,495 | 3.64M |
| 371 | VRCA | Verrica Pharmaceuticals Inc. | 107.71M | - | 3,237 | 35.58M |
| 372 | KALA | KALA BIO, Inc. | 105.96M | 4.59% | 488,163 | - |
| 373 | CUE | Cue Biopharma, Inc. | 105.47M | 6.51% | 661,418 | 27.47M |
| 374 | ANIX | Anixa Biosciences, Inc. | 103.94M | -1.27% | 25,930 | - |
| 375 | NTHI | NeOnc Technologies Holdings, Inc. | 103.78M | 1.48% | 6,552 | 39.99K |
| 376 | NRXP | NRx Pharmaceuticals, Inc. | 102.41M | 0.32% | 341,333 | 1.23M |
| 377 | COYA | Coya Therapeutics, Inc. | 99.93M | 2.16% | 17,545 | 7.95M |
| 378 | PMN | ProMIS Neurosciences, Inc. | 99.63M | 0.91% | 7,492 | - |
| 379 | ALDX | Aldeyra Therapeutics, Inc. | 99.30M | 3.77% | 185,057 | - |
| 380 | RANI | Rani Therapeutics Holdings, Inc. | 95.82M | 2.13% | 93,620 | 1.63M |
| 381 | BMEA | Biomea Fusion, Inc. | 95.80M | -3.28% | 716,939 | - |
| 382 | NRXS | NeurAxis, Inc. | 92.85M | -0.12% | 49,981 | 3.57M |
| 383 | INO | Inovio Pharmaceuticals, Inc. | 91.77M | 1.82% | 341,347 | 65.34K |
| 384 | OKYO | OKYO Pharma Limited | 88.17M | 1.20% | 5,086 | - |
| 385 | ACET | Adicet Bio, Inc. | 88.04M | -0.12% | 5,758 | - |
| 386 | LONA | LeonaBio, Inc. | 87.74M | 5.90% | 1,435 | - |
| 387 | GOSS | Gossamer Bio, Inc. | 87.57M | 0.89% | 441,906 | 48.47M |
| 388 | PYPD | PolyPid Ltd. | 85.68M | 1.13% | 13,749 | - |
| 389 | PTHS | Pelthos Therapeutics Inc. | 83.82M | -0.08% | 5,408 | 16.80M |
| 390 | MAIA | MAIA Biotechnology, Inc. | 83.73M | 2.99% | 215,568 | - |
| 391 | CSBR | Champions Oncology, Inc. | 83.32M | 0.17% | 218 | 57.95M |
| 392 | ACRV | Acrivon Therapeutics, Inc. | 83.30M | 2.87% | 430,140 | - |
| 393 | ATYR | aTyr Pharma, Inc. | 81.82M | 0.12% | 124,537 | 190.00K |
| 394 | GANX | Gain Therapeutics, Inc. | 80.89M | 1.86% | 191,853 | - |
| 395 | EXOZ | eXoZymes, Inc. | 79.30M | 3.58% | 115 | -700.00 |
| 396 | ATHE | Alterity Therapeutics Limited | 78.54M | 0.53% | 1,979 | 4.43M |
| 397 | ICCC | ImmuCell Corporation | 77.89M | -1.37% | 1,079 | 27.64M |
| 398 | XBIT | XBiotech Inc. | 77.44M | -0.39% | 5,007 | - |
| 399 | MCRB | Seres Therapeutics, Inc. | 77.17M | 5.78% | 13,696 | 789.00K |
| 400 | FBIO | Fortress Biotech, Inc. | 76.64M | 2.15% | 34,012 | 63.26M |
| 401 | PLRX | Pliant Therapeutics, Inc. | 75.85M | 2.08% | 20,678 | - |
| 402 | PMVP | PMV Pharmaceuticals, Inc. | 75.19M | 1.44% | 101,055 | - |
| 403 | QTTB | Q32 Bio Inc. | 74.61M | 1.19% | 66,016 | 53.74M |
| 404 | TCRX | TScan Therapeutics, Inc. | 74.53M | 1.64% | 42,946 | 10.33M |
| 405 | ANVS | Annovis Bio, Inc. | 72.52M | 5.00% | 170,451 | - |
| 406 | FLNA | Filana Therapeutics, Inc. | 72.22M | -0.99% | 84,450 | - |
| 407 | RLYB | Rallybio Corporation | 71.15M | 42.93% | 7,614,401 | 858.00K |
| 408 | SGMO | Sangamo Therapeutics, Inc. | 70.92M | 26.81% | 12,206,404 | 39.55M |
| 409 | IBO | Impact BioMedical Inc. | 69.05M | -2.53% | 30,823 | 32.00K |
| 410 | ACTU | Actuate Therapeutics, Inc. | 69.00M | -3.00% | 9,290 | - |
| 411 | OSTX | OS Therapies Incorporated | 68.95M | 1.87% | 263,870 | - |
| 412 | MNOV | MediciNova, Inc. | 68.91M | - | 1,676 | 409.66K |
| 413 | ESLA | Estrella Immunopharma, Inc. | 68.26M | -1.84% | 2,433 | - |
| 414 | IMMP | Immutep Limited | 64.92M | 3.28% | 283,652 | 5.28M |
| 415 | IMA | ImageneBio, Inc. | 63.87M | 0.88% | 3,865 | 800.00K |
| 416 | BYSI | BeyondSpring Inc. | 63.32M | 3.36% | 583 | 1.88M |
| 417 | CING | Cingulate Inc. | 62.39M | -0.09% | 96,813 | - |
| 418 | HYFT | MindWalk Holdings Corp. | 60.59M | 0.83% | 10,238 | 20.70M |
| 419 | INKT | MiNK Therapeutics, Inc. | 60.24M | 4.48% | 1,707 | - |
| 420 | PDSB | PDS Biotechnology Corporation | 59.16M | 8.09% | 227,673 | - |
| 421 | IBIO | iBio, Inc. | 55.66M | -3.14% | 428,027 | 300.00K |
| 422 | TIL | Instil Bio, Inc. | 55.48M | 3.54% | 12,293 | - |
| 423 | MGX | Metagenomi Therapeutics, Inc. | 53.80M | 2.88% | 25,307 | 25.21M |
| 424 | KZR | Kezar Life Sciences, Inc. | 53.71M | -0.82% | 15,073 | - |
| 425 | ENTX | Entera Bio Ltd. | 51.75M | 0.91% | 41,912 | 42.00K |
| 426 | RADX | Radiopharm Theranostics Limited | 51.19M | -1.53% | 8,954 | 10.86M |
| 427 | HYPD | Hyperion DeFi, Inc. | 50.69M | 6.46% | 131,954 | 813.46K |
| 428 | ATOS | Atossa Therapeutics, Inc. | 48.74M | 6.19% | 31,536 | - |
| 429 | XLO | Xilio Therapeutics, Inc. | 48.28M | 0.36% | 15,782 | 43.77M |
| 430 | DWTX | Dogwood Therapeutics, Inc. | 47.44M | -2.72% | 19,900 | - |
| 431 | TELO | Telomir Pharmaceuticals, Inc. | 47.30M | -1.72% | 14,901 | - |
| 432 | NTRB | Nutriband Inc. | 46.80M | -0.26% | 1,445 | 2.04M |
| 433 | PSTV | Plus Therapeutics, Inc. | 43.23M | 3.45% | 25,316 | 5.21M |
| 434 | MREO | Mereo BioPharma Group plc | 42.44M | 2.27% | 228,766 | 500.00K |
| 435 | DARE | Daré Bioscience, Inc. | 42.37M | 24.36% | 909,223 | 1.03M |
| 436 | LITS | Lite Strategy, Inc. | 41.45M | 0.88% | 10,296 | - |
| 437 | RNXT | RenovoRx, Inc. | 41.26M | 3.69% | 28,683 | 1.12M |
| 438 | ATRA | Atara Biotherapeutics, Inc. | 41.20M | -1.22% | 13,584 | 120.77M |
| 439 | SNSE | Sensei Biotherapeutics, Inc. | 40.21M | 11.28% | 18,219 | - |
| 440 | INMB | INmune Bio Inc. | 39.61M | -1.32% | 56,425 | 50.00K |
| 441 | PTN | Palatin Technologies, Inc. | 38.81M | 7.36% | 4,086 | 8.96M |
| 442 | ALGS | Aligos Therapeutics, Inc. | 38.74M | 2.79% | 29,752 | 2.19M |
| 443 | LIXT | Lixte Biotechnology Holdings, Inc. | 38.57M | -0.59% | 319 | - |
| 444 | EVAX | Evaxion A/S | 37.82M | 0.89% | 2,654 | 7.53M |
| 445 | APLM | Apollomics, Inc. | 36.84M | 3.42% | 3,571 | 8.84M |
| 446 | VERU | Veru Inc. | 36.59M | 0.88% | 12,660 | 16.89M |
| 447 | ATNM | Actinium Pharmaceuticals, Inc. | 36.48M | 3.54% | 74,282 | 90.00K |
| 448 | CRVO | CervoMed Inc. | 35.65M | 3.77% | 12,900 | 4.01M |
| 449 | GRCE | Grace Therapeutics, Inc. | 35.28M | -2.56% | 118,095 | - |
| 450 | BOLD | Boundless Bio, Inc. | 35.18M | - | 7,696 | - |
| 451 | PLUR | Pluri Inc. | 34.96M | 3.84% | 343 | 1.34M |
| 452 | HOWL | Werewolf Therapeutics, Inc. | 34.63M | -1.45% | 21,364 | 1.14M |
| 453 | NXTC | NextCure, Inc. | 33.91M | 0.43% | 7,789 | - |
| 454 | QNTM | Quantum BioPharma Ltd. | 32.56M | -6.85% | 59,704 | - |
| 455 | IGC | IGC Pharma, Inc. | 32.36M | -2.21% | 120,187 | 1.11M |
| 456 | NRSN | NeuroSense Therapeutics Ltd. | 31.81M | 0.38% | 58,620 | - |
| 457 | NNVC | NanoViricides, Inc. | 30.66M | 9.23% | 314,416 | - |
| 458 | BCTX | BriaCell Therapeutics Corp. | 30.29M | 1.65% | 25,933 | - |
| 459 | TVRD | Tvardi Therapeutics, Inc. | 29.83M | 1.27% | 4,176 | - |
| 460 | SNTI | Senti Biosciences Holdings, Inc. | 29.74M | -6.37% | 293,711 | 22.00K |
| 461 | TPST | Tempest Therapeutics, Inc. | 29.55M | 0.98% | 23,756 | - |
| 462 | LSTA | Lisata Therapeutics, Inc. | 29.35M | 3.83% | 18,381 | 170.00K |
| 463 | KYNB | Kyntra Bio, Inc. | 29.26M | 1.97% | 2,785 | 6.44M |
| 464 | SKYE | Skye Bioscience, Inc. | 29.24M | 1.07% | 15,097 | - |
| 465 | PLRZ | Polyrizon Ltd. | 29.20M | -2.50% | 4,482 | - |
| 466 | RNTX | Rein Therapeutics Inc. | 29.16M | 0.97% | 425,662 | - |
| 467 | NEUP | Neuphoria Therapeutics Inc. | 28.28M | 0.48% | 2,085 | 14.99M |
| 468 | DYAI | Dyadic International, Inc. | 28.06M | -2.53% | 635 | 3.09M |
| 469 | TVGN | Tevogen Bio Holdings Inc. | 27.23M | -1.80% | 498 | - |
| 470 | OTLK | Outlook Therapeutics, Inc. | 27.19M | -0.88% | 1,101,206 | 205.70K |
| 471 | JSPR | Jasper Therapeutics, Inc. | 27.16M | 4.27% | 20,284 | - |
| 472 | CELU | Celularity Inc. | 26.53M | -3.87% | 172,514 | 26.55M |
| 473 | MRKR | Marker Therapeutics, Inc. | 26.18M | 7.53% | 34,221 | 3.55M |
| 474 | VTGN | Vistagen Therapeutics, Inc. | 25.75M | 3.84% | 283,279 | 789.00K |
| 475 | BRNS | Barinthus Biotherapeutics plc | 25.73M | -3.18% | 4,188 | 14.97M |
| 476 | LGVN | Longeveron Inc. | 25.46M | 2.19% | 75,484 | 1.20M |
| 477 | ABVC | ABVC BioPharma, Inc. | 25.45M | - | 19,198 | 797.92K |
| 478 | LTRN | Lantern Pharma Inc. | 23.53M | -1.00% | 36,902 | - |
| 479 | CRIS | Curis, Inc. | 23.22M | -1.91% | 41,068 | 9.44M |
| 480 | KTTA | Pasithea Therapeutics Corp. | 23.19M | 10.58% | 252,421 | - |
| 481 | AEON | AEON Biopharma, Inc. | 22.78M | 1.17% | 11,198 | - |
| 482 | SER | Serina Therapeutics, Inc. | 22.78M | 1.82% | 6,265 | 130.00K |
| 483 | VYNE | VYNE Therapeutics Inc. | 21.54M | 0.83% | 69,925 | 570.00K |
| 484 | XCUR | Exicure, Inc. | 21.45M | 3.86% | 5,301 | 500.00K |
| 485 | QNCX | Quince Therapeutics, Inc. | 20.78M | -4.14% | 205,570 | - |
| 486 | CVKD | Cadrenal Therapeutics, Inc. | 20.38M | 4.25% | 11,543 | - |
| 487 | ALLR | Allarity Therapeutics, Inc. | 20.09M | -2.31% | 46,962 | 320.00K |
| 488 | COCP | Cocrystal Pharma, Inc. | 19.16M | 0.72% | 18,074 | - |
| 489 | LPCN | Lipocine Inc. | 18.78M | 0.43% | 22,728 | 1.98M |
| 490 | CTXR | Citius Pharmaceuticals, Inc. | 18.64M | -1.74% | 115,341 | 3.94M |
| 491 | OSRH | OSR Holdings, Inc. | 18.54M | -12.08% | 2,091,486 | 2.91M |
| 492 | ICU | SeaStar Medical Holding Corporation | 17.61M | 0.92% | 20,496 | 1.23M |
| 493 | LEXX | Lexaria Bioscience Corp. | 17.27M | -2.02% | 17,700 | 368.00K |
| 494 | GNTA | Genenta Science S.p.A. | 17.22M | - | 3,829 | - |
| 495 | NCEL | NewcelX Ltd. | 17.00M | -3.12% | 10,525 | - |
| 496 | TOVX | Theriva Biologics, Inc. | 16.71M | -6.55% | 1,194,388 | - |
| 497 | TRAW | Traws Pharma, Inc. | 15.64M | 3.36% | 22,895 | 2.79M |
| 498 | PASG | Passage Bio, Inc. | 15.62M | -2.01% | 17,251 | - |
| 499 | INAB | IN8bio, Inc. | 15.16M | 2.67% | 13,011 | - |
| 500 | CVM | CEL-SCI Corporation | 14.57M | -21.05% | 491,251 | - |